Legend Biotech (LEGN) Consolidated Net Income (2019 - 2025)
Historic Consolidated Net Income for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$38.5 million.
- Legend Biotech's Consolidated Net Income rose 6697.58% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$219.5 million, marking a year-over-year decrease of 19441.9%. This contributed to the annual value of -$158.1 million for FY2024, which is 3019110.33% down from last year.
- Legend Biotech's Consolidated Net Income amounted to -$38.5 million in Q3 2025, which was up 6697.58% from -$124.2 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Consolidated Net Income registered a high of $59.8 million during Q1 2024, and its lowest value of -$403.6 million during Q4 2021.
- Over the past 5 years, Legend Biotech's median Consolidated Net Income value was -$91.6 million (recorded in 2021), while the average stood at -$91.2 million.
- Per our database at Business Quant, Legend Biotech's Consolidated Net Income crashed by 3228891.42% in 2022 and then soared by 2733359.74% in 2024.
- Legend Biotech's Consolidated Net Income (Quarter) stood at -$403.6 million in 2021, then surged by 66.41% to -$135.6 million in 2022, then surged by 99.89% to -$148806.0 in 2023, then surged by 27333.6% to $40.5 million in 2024, then crashed by 194.9% to -$38.5 million in 2025.
- Its last three reported values are -$38.5 million in Q3 2025, -$124.2 million for Q2 2025, and -$97.3 million during Q1 2025.